Total Voting Rights

Summary by AI BETAClose X

Hemogenyx Pharmaceuticals plc announced on 27 February 2026 that its total issued share capital comprises 6,425,429 ordinary shares of 1p each, with no shares held in treasury, resulting in a total of 6,425,429 voting rights. This figure serves as the denominator for shareholders to determine notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules regarding their investment or changes in interest in the company's share capital.

Disclaimer*

UK 100

Latest directors dealings